Strs Ohio Pulmonx Corp Transaction History

Strs Ohio

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$8.71 - $14.65 $32,227 - $54,205	3,700 Added 71.15%	8,900 $82,000
Q4 2023 Jan 30, 2024	SELL	$7.89 - $13.14 $24,459 - $40,734	-3,100 Reduced 37.35%	5,200 $66,000
Q3 2023 Oct 26, 2023	BUY	$9.88 - $14.0 $82,004 - $116,200	8,300 New	8,300 $85,000
Q1 2021 Apr 23, 2021	SELL	$44.0 - $67.54 $123,200 - $189,112	-2,800 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$39.31 - $69.02 $110,068 - $193,256	2,800 New	2,800 $193,000

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.